What is Trial Management Associates?
Trial Management Associates (TMA) operates as a specialized network of private physician practices dedicated to the execution of phase II-IV clinical drug trials and research studies. By bridging the gap between pharmaceutical sponsors and private medical groups, TMA provides a robust framework for managing complex research protocols. The company leverages a highly qualified team of investigators, site managers, and research coordinators to ensure that all data generated is statistically sound and compliant with industry standards. Their model not only streamlines the recruitment of study volunteers but also optimizes the efficiency of industry-sponsored trials, thereby accelerating the path to medical breakthroughs.
How much funding has Trial Management Associates raised?
Trial Management Associates has raised a total of $106K across 1 funding round:
Debt
$106K
Debt (2021): $106K with participation from PPP
Key Investors in Trial Management Associates
PPP
Public-Private Partnership
What's next for Trial Management Associates?
With the recent influx of capital, Trial Management Associates is expected to focus on expanding its footprint across additional private medical practice groups, thereby increasing its capacity for large-scale clinical research. The strategic deployment of these funds will likely prioritize the integration of advanced data management technologies and the strengthening of its investigator network. As the company moves into this next phase of growth, it remains committed to improving patient outcomes through rigorous, high-quality research execution, positioning itself as a critical partner for pharmaceutical companies navigating the complexities of modern drug development.
See full Trial Management Associates company page
